fda warning unapproved peptide products bpc-157 advisers back first four of seven peptides under review for looser rules | The Mighty 790 KFGO FDA's Overreach on Compounded Peptides

FDA's Overreach on Compounded Peptides fda warning bpc 157 unapproved peptide Peptide products are being promoted on social media. They are unapproved medicines and pose serious health risks with little evidence they work and no FDA panel considers loosening regulations for some peptides The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link

SKU: 18661532316 · From www.asociacionchamorro.org